NATALIE BAKER: Open Payments
NPI 1912402561 · GRAND BLANC, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$540 in 26 payments from 15 companies in 2025. Trend: 2023 $366 · 2024 $633 · 2025 $540
Food & beverage: $540
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $90 |
| Amgen Inc. | 4 | $67 |
| RGH Enterprises LLC | 2 | $66 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Novo Nordisk Inc | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Lilly USA, LLC | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
Products named: Veozah, OTEZLA, Wegovy, LEQVIO, MOUNJARO, REXULTI, Kerendia, GEMTESA.
Industry payments across MI — which companies pay providers there.
